In August, the U pabulum and Drug ...

In August, the U pabulum and Drug Administration (FDA) approved brace fixed-dose combination drug products for the treatment of human immunodeficiency virus (HIV) infection: Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine). These medicines are indicated for use in combination with other antiretroviral unsalable articles from different classes. Combining the mix with drugss in a single medication should make treatment regimens les complicated for patients to succeed More information is available online at http://www.fda.gov/bbs/topics/news/2004/NEW01099.html. The FDA also has approved Sculptra, an injectable filler to correct facial fat los in patients with HIV infection. It is the first approved treatment for lipoatrophy, or facial wasting, a sinking of the cheeks, views and temples caused by the los of fat tissue beneath the skin. For more information, go on foot to http://www.fda.gov/bbs/topics/news/2004/NEW01100.html.

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group